Page last updated: 2024-09-05

dabigatran and Body Weight

dabigatran has been researched along with Body Weight in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	4 (44.44)	24.3611
2020's	5 (55.56)	2.80

Authors

Authors	Studies
Bansal, A; Eisele, CD; Jain, R; Julian, K; Mausteller, KG; Patel, P	1
Branam, DL; Covert, K	1
Bakker, ECMD; Borst, JM; Bosma, LBE; Hudig, F; Mairuhu, ATA; Rier, M; van Rein, N; Visser, LE; Vukadin, N; Wilms, EB	1
Albisetti, M; Bergstrand, M; Bomgaars, L; Brandão, LR; Brueckmann, M; Chalmers, E; Gropper, S; Halton, J; Huang, F; Ibrahim, MMA; Joseph, D; Luciani, M; Mitchell, LG; Röshammar, D; Tartakovsky, I	1
Cornu, P; Dupont, A; Moudallel, S; Steurbaut, S	1
Kemkes-Matthes, B	1
Abrahams, SR; Divanovic, S; Flick, MJ; Goss, A; Kopec, AK; Luyendyk, JP; Mackman, N; Mullins, ES; Owens, AP; Palumbo, JS; Thornton, S; van Ryn, J; Weiler, H	1
Connolly, SJ; Dansirikul, C; Ezekowitz, MD; Haertter, S; Lehr, T; Liesenfeld, KH; Reilly, PA; Staab, A; Wallentin, L; Yusuf, S	1
Baumhäkel, M; Böhm, M; Kratz, MT; Lee, IO; Schirmer, SH	1

Reviews

3 review(s) available for dabigatran and Body Weight

Article	Year
Anticoagulation and BMI: effect of high body weight on the safety and efficacy of direct oral anticoagulants. Future cardiology, 2022, Volume: 18, Issue:10 Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Body Mass Index; Body Weight; Dabigatran; Hemorrhage; Humans; Obesity; Pyridones; Rivaroxaban; Stroke; Vitamin K	2022
Direct-acting oral anticoagulant use at extremes of body weight: Literature review and recommendations. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2020, 05-19, Volume: 77, Issue:11 Topics: Anticoagulants; Body Weight; Dabigatran; Drug Dosage Calculations; Factor Xa Inhibitors; Humans; Obesity; Overweight; Pyrazoles; Pyridones; Rivaroxaban; Venous Thromboembolism	2020
[Anticoagulation-direct oral anticoagulants]. Der Internist, 2017, Volume: 58, Issue:6 Topics: Administration, Oral; Anticoagulants; Antidotes; Atrial Fibrillation; Biological Availability; Body Weight; Dabigatran; Humans; Thromboembolism; Vitamin K	2017

Trials

2 trial(s) available for dabigatran and Body Weight

Article	Year
Body weight is negatively associated with direct oral anticoagulant trough concentrations in dabigatran and apixaban users. British journal of haematology, 2020, Volume: 191, Issue:5 Topics: Administration, Oral; Aged; Anticoagulants; Body Weight; Cross-Sectional Studies; Dabigatran; Female; Humans; Male; Pyrazoles; Pyridones	2020
Population pharmacokinetic analysis of the oral thrombin inhibitor dabigatran etexilate in patients with non-valvular atrial fibrillation from the RE-LY trial. Journal of thrombosis and haemostasis : JTH, 2011, Volume: 9, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Atrial Fibrillation; Benzimidazoles; Body Weight; Dabigatran; Drug Interactions; Ethnicity; Hemoglobins; Humans; Kidney Diseases; Middle Aged; Models, Theoretical; Pharmacokinetics; Plasma; Prodrugs; Pyridines; Thrombin; Young Adult	2011

Article

Year

Body weight is negatively associated with direct oral anticoagulant trough concentrations in dabigatran and apixaban users.

British journal of haematology, 2020, Volume: 191, Issue:5

Topics: Administration, Oral; Aged; Anticoagulants; Body Weight; Cross-Sectional Studies; Dabigatran; Female; Humans; Male; Pyrazoles; Pyridones

2020

Population pharmacokinetic analysis of the oral thrombin inhibitor dabigatran etexilate in patients with non-valvular atrial fibrillation from the RE-LY trial.

Journal of thrombosis and haemostasis : JTH, 2011, Volume: 9, Issue:11

Topics: Adult; Aged; Aged, 80 and over; Atrial Fibrillation; Benzimidazoles; Body Weight; Dabigatran; Drug Interactions; Ethnicity; Hemoglobins; Humans; Kidney Diseases; Middle Aged; Models, Theoretical; Pharmacokinetics; Plasma; Prodrugs; Pyridines; Thrombin; Young Adult

2011

Other Studies

4 other study(ies) available for dabigatran and Body Weight

Article	Year
Pharmacokinetic modeling and simulation support for age- and weight-adjusted dosing of dabigatran etexilate in children with venous thromboembolism. Journal of thrombosis and haemostasis : JTH, 2021, Volume: 19, Issue:5 Topics: Adolescent; Adult; Antithrombins; Body Weight; Child; Computer Simulation; Dabigatran; Female; Humans; Male; Venous Thromboembolism	2021
Determinants for under- and overdosing of direct oral anticoagulants and physicians' implementation of clinical pharmacists' recommendations. British journal of clinical pharmacology, 2022, Volume: 88, Issue:2 Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Body Weight; Cross-Sectional Studies; Dabigatran; Humans; Pharmacists; Physicians; Retrospective Studies; Rivaroxaban; Stroke	2022
Thrombin promotes diet-induced obesity through fibrin-driven inflammation. The Journal of clinical investigation, 2017, Aug-01, Volume: 127, Issue:8 Topics: Adipose Tissue; Adiposity; Amino Acid Motifs; Animals; Blood Glucose; Body Composition; Body Weight; Coagulants; Dabigatran; Diet, High-Fat; Fatty Liver; Female; Fibrin; Genotype; Homozygote; Inflammation; Liver; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Obesity; Thrombin; Weight Gain	2017
The effects of direct thrombin inhibition with dabigatran on plaque formation and endothelial function in apolipoprotein E-deficient mice. The Journal of pharmacology and experimental therapeutics, 2012, Volume: 343, Issue:2 Topics: Animals; Antithrombins; Apolipoproteins E; Benzimidazoles; beta-Alanine; Blood Pressure; Body Weight; Collagen; Dabigatran; Endothelium, Vascular; Ethidium; Fluorescent Dyes; Heart Rate; Male; Mice; Mice, Knockout; Microscopy, Fluorescence; Oxidative Stress; Plaque, Atherosclerotic; Thrombin	2012